Previous Close | 7.32 |
Open | 7.30 |
Bid | 7.50 x 0 |
Ask | 7.54 x 0 |
Day's Range | 7.26 - 7.64 |
52 Week Range | 3.84 - 12.85 |
Volume | |
Avg. Volume | 718,757 |
Market Cap | 412.142M |
Beta (5Y Monthly) | 2.71 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.63 |
Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 9.50 |
Aurora Cannabis' new collaboration on the Genome BC-Funded Project addresses distinct cannabis aromas.
Announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia ...
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –—the Canadian based leading global medical cannabis company, today announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia (Genome BC), a not-for-profit organization supporting world-class genomics research and innovation in British Columbia. The project, Genomics-enabled Aroma Breeding in Cannabis, will directly support Aurora's genetics work the project, is led by Drs. Jose Celedon, Principal Scie